NeuroSigma.png
NeuroSigma Establishes Singapore Subsidiary
July 12, 2023 11:00 ET | NeuroSigma, Inc.
LOS ANGELES, July 12, 2023 (GLOBE NEWSWIRE) -- NeuroSigma, Inc. (“NeuroSigma”) today announced the launch of NeuroSigma Pte, Ltd., a Singapore corporation (“NeuroSigma Singapore”), representing...
BES_Mark.jpg
CANOPY ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Canopy Growth Corporation and Encourages Investors to Contact the Firm
June 19, 2023 21:00 ET | Bragar Eagel & Squire
NEW YORK, June 19, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, reminds investors that a class action lawsuit has been filed against...
SNS-INSIDER-300X300.jpg
Bioelectronics and Biosensors Market Surpass USD 56.01366 Billion by 2030 as a Result of Growing Demand for Remote Patient Monitoring | Published By SNS Insider
June 15, 2023 08:45 ET | SNS Insider pvt ltd
Pune, June 15, 2023 (GLOBE NEWSWIRE) -- According to a report from SNS Insider, "The bioelectronics and biosensors market reached a value of USD 27.5 billion in 2022 and is projected to reach USD...
NeuroSigma.png
NeuroSigma Announces New Telehealth Option for Patients and Caregivers Interested in eTNS for Pediatric ADHD
March 01, 2023 11:00 ET | NeuroSigma, Inc.
LOS ANGELES, March 01, 2023 (GLOBE NEWSWIRE) -- NeuroSigma today announced a new option for patients and caregivers seeking a telehealth evaluation for the Monarch eTNS System®. NeuroSigma is a Los...
NeuroSigma.png
NeuroSigma Announces Strategic Digital Marketing Partnership with Data360
January 31, 2023 09:00 ET | NeuroSigma, Inc.
LOS ANGELES, Jan. 31, 2023 (GLOBE NEWSWIRE) -- NeuroSigma, Inc., a Los Angeles-based bioelectronics company commercializing external trigeminal nerve stimulation (eTNS) technology for treating...
law
New to The Street Partners with Law Firm Anthony L.G., PLLC to Air Monthly Segments
December 15, 2022 09:00 ET | FMW Media Works Corp
NEW YORK, Dec. 15, 2022 (GLOBE NEWSWIRE) -- FMW Media's New to The Street announces that it has entered into a multi-year partnership with legal firm Anthony L.G., PLLC. Founding partner Laura...
NeuroSigma.png
NeuroSigma Announces that Enrollment Commences in Two Large, Double-Blind Trials of eTNS for Pediatric ADHD
November 08, 2022 10:00 ET | NeuroSigma, Inc.
Trials recruiting subjects at UCLA and Seattle Children’s Hospital in the United States, and at King’s College London and the University of Southampton in the United Kingdom Trials sponsored by the...
Featured Image for TrüNorth Global
International Venture Capitalist and Founder/CEO of TrüNorth Global and Waystone Capital Comes Home to Invest and Reimagine Hometown
November 04, 2022 10:00 ET | TrüNorth Global
CHARLOTTE, N.C., Nov. 04, 2022 (GLOBE NEWSWIRE) -- William Kirk Eskridge, born and raised in Sturgis, Mississippi, is currently building Highland Oaks, an event, festival, and music venue on...
NeuroSigma.png
NeuroSigma Announces Commercial Launch of The Monarch eTNS® System for the Treatment of Pediatric ADHD at Annual Meeting of the American Academy of Child and Adolescent Psychiatry
October 17, 2022 09:00 ET | NeuroSigma, Inc.
LOS ANGELES, Oct. 17, 2022 (GLOBE NEWSWIRE) -- NeuroSigma, Inc., a Los Angeles-based bioelectronics company, today announced the commercial launch of The Monarch eTNS System at the annual meeting of...
Logo.png
The Global Physiotherapy Equipment Market to Grow at a CAGR of 7.44% by 2027 | DelveInsight
September 20, 2022 13:00 ET | DelveInsight Business Research LLP
New York, USA, Sept. 20, 2022 (GLOBE NEWSWIRE) -- The Global Physiotherapy Equipment Market to Grow at a CAGR of 7.44% by 2027 | DelveInsight The physiotherapy equipment market is expanding owing...